Search results
H. Michael Shepard (born 1949) is an American cancer researcher who was awarded the 2007 Harvard Medical School Warren Alpert Foundation Prize and the 2019 Lasker Clinical research award, which he shared with Dennis Slamon and Axel Ullrich for their development of Herceptin
Mar 15, 2024 · In this World View, H. Michael Shepard describes his personal story behind the discovery of trastuzumab, 25 years since its FDA approval for HER2-overexpressing breast cancers.
Michael Shepard, MD specializes in orthopaedic surgery. He renders the most comprehensive care for knee, elbow and shoulder injuries. Dr. Shepard uses the latest medical technology with the state of art medical facility to provide his patients the best possible outcome.
Nov 30, 2021 · Dr. Michael Shepard is the President and CSO of Enosi Life Sciences, a company developing biologics for autoimmune and cancer diseases. He won the 2019 Lasker-DeBakey Award for inventing Herceptin, a targeted antibody therapy for breast cancer.
Sep 24, 2019 · Dr. H. Michael Shepard and his team have identified a critical breast cancer biomarker and developed the drug Herceptin, which can treat more than just breast cancer.
Mar 3, 2023 · On this episode of the Artmatcher podcast, Michael Shepard, Deloitte’s Global Financial Crime Practice leader, discusses art, sanctions, financial crime, and...
- 33 min
- 40
- Artmatcher
People also ask
Who is Dr Michael Shepard?
Who is David Shepard?
Who is Dr Shepard & how did he become a doctor?
How did Shepard become part of Genentech's TNF project?
Sep 10, 2019 · Shepard initially worked with David Goeddel, who is best known for cloning human insulin, growth hormones, and many of Genentech’s early products. Eventually, Shepard moved over to the Pharmacology Department and became interested in generating medicines that were not just cloned genes.
